Predict your next investment

Angel Investor (Individual)
english.martinvarsavsky.net

See what CB Insights has to offer

Investments

32

Portfolio Exits

8

About Martin Varsavsky

Martin Varsavsky is an Argentine/Spanish entrepreneur, founder of seven companies in the past 20 years.In 1984, while still in college, Martin Varsavsky started his first business, Urban Capital Corporation, one of the early leaders of the loft movement in downtown Manhattan. This was soon followed in 1986 by Medicorp Services, a Canadian biotechnology company, a pioneer in AIDS and PSA testing. His third business, Viatel Ltd., Martin's first venture into the world of telecom, was founded in 1990. This company is best known for inventing call back and building the first pan European fiber optic network ahead of liberalization.MV's best-known ventures were founded during the last decade. In 1998 MV started Jazztel Telecomunicaciones (Jazztel), Spain's second largest publicly traded telecom operator. In 1999 he founded Ya.com, Spain's third largest internet web site/DSL provider that includes the second largest Spanish language web agency www.viajar.com. But not all of MV's companies were successful. In 2000 he started Germany's largest ASP, Einsteinet, and the company was sold in 2003 at no return to him or investors.Martin's current venture is FON, an innovative WiFi start up founded in February 2006 and headquartered in Madrid, Spain, with some 100 employees located around the world. FON's mission is to make WiFi universal and free by creating a unified global community of members who share WiFi. The FON Community already has close to 700,000 members and has become the world's largest WiFi community.FON has raised more than 30M Euro in financing from among others Skype, Google, Index Ventures, Sequoia Capital and BT. These leading Internet and communications companies have shown the industry's support for FON's vision and business model.(source: http://english.martinvarsavsky.net)

Martin Varsavsky Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Martin Varsavsky News

Tympa Health Technologies Raises $8M in Seed Funding

Feb 20, 2022

Tympa Health Technologies , a London, UK-based digital health company, raised $8M in Seed funding. The round was led by Maurice Ferre and Arjun Desai with participation from Jim Breyer, Anil Sethi, Martin Varsavsky, Carlos Gallardo, Fred Moll, Elan Katz, Manny Kadre and Imran Hakim. TympaHealth will also be appointing Arjun Desai and Karin Ajmani to their board of directors. The company intends to use the funds to accelerate its expansion across the U.K., Europe & U.S. Founded by CEO Dr. Krishan Ramdoo, TympaHealth is a digital health company that uses patented technology to allow for comprehensive hearing health assessments to be performed in point-of-care settings, enabling earlier disease detection and access to cost-effective care. By combining proprietary hardware and AI-enabled software, TympaHealth created a hearing assessment platform available to patients outside traditional primary or secondary care settings, like pharmacies, retail stores, and assisted living facilities. Fully portable and intuitive, within a few minutes, the point of care tool provides patients (and their providers) with the information to detect disease and manage their hearing health through high-resolution ear drum visualization, ear wax removal and a real-time screening audiogram. The system is CE marked and FDA registered. FinSMEs 20/02/2022

Martin Varsavsky Investments

32 Investments

Martin Varsavsky has made 32 investments. Their latest investment was in TympaHealth as part of their Seed VC on February 2, 2022.

CBI Logo

Martin Varsavsky Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

2/17/2022

Seed VC

TympaHealth

$8M

Yes

8

10/21/2021

Series A

Pomelo

$35M

Yes

9

6/3/2021

Angel

NUE Life Health

$3.3M

Yes

4

1/24/2020

Seed

Subscribe to see more

$99M

Subscribe to see more

10

6/3/2019

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/17/2022

10/21/2021

6/3/2021

1/24/2020

6/3/2019

Round

Seed VC

Series A

Angel

Seed

Series C

Company

TympaHealth

Pomelo

NUE Life Health

Subscribe to see more

Subscribe to see more

Amount

$8M

$35M

$3.3M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

8

9

4

10

10

Martin Varsavsky Portfolio Exits

8 Portfolio Exits

Martin Varsavsky has 8 portfolio exits. Their latest portfolio exit was Busuu on January 13, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/13/2022

Acquired

$99M

2

4/19/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

6/15/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

2/23/2016

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

8/17/2015

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

Date

1/13/2022

4/19/2021

6/15/2020

2/23/2016

8/17/2015

Exit

Acquired

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

0

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.